Geode Capital Management, LLC Paratek Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$1.52 - $2.8 $41,129 - $75,765	-27,059 Reduced 5.8%	439,736 $971,000
Q1 2023 May 15, 2023	BUY	$1.37 - $2.54 $3,230 - $5,989	2,358 Added 0.51%	466,795 $1.19 Million
Q4 2022 Feb 13, 2023	BUY	$1.67 - $2.51 $37,578 - $56,480	22,502 Added 5.09%	464,437 $868,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $2.93 $11,007 - $16,454	5,616 Added 1.29%	441,935 $1.14 Million
Q2 2022 Aug 12, 2022	SELL	$1.73 - $3.09 $639,743 - $1.14 Million	-369,794 Reduced 45.87%	436,319 $842,000
Q1 2022 May 13, 2022	BUY	$2.94 - $4.77 $133,173 - $216,066	45,297 Added 5.95%	806,113 $2.39 Million
Q4 2021 Feb 11, 2022	BUY	$4.07 - $5.3 $257,203 - $334,933	63,195 Added 9.06%	760,816 $3.42 Million
Q3 2021 Nov 12, 2021	SELL	$4.7 - $7.24 $125,894 - $193,930	-26,786 Reduced 3.7%	697,621 $3.39 Million
Q2 2021 Aug 13, 2021	BUY	$6.81 - $10.93 $200,159 - $321,254	29,392 Added 4.23%	724,407 $4.94 Million
Q1 2021 May 12, 2021	BUY	$6.14 - $8.31 $370,579 - $501,550	60,355 Added 9.51%	695,015 $4.91 Million
Q4 2020 Feb 12, 2021	BUY	$4.58 - $7.14 $201,579 - $314,252	44,013 Added 7.45%	634,660 $3.97 Million
Q3 2020 Nov 13, 2020	BUY	$4.19 - $6.69 $19,022 - $30,372	4,540 Added 0.77%	590,647 $3.2 Million
Q2 2020 Aug 13, 2020	BUY	$2.97 - $5.22 $37,745 - $66,340	12,709 Added 2.22%	586,107 $3.06 Million
Q1 2020 May 14, 2020	BUY	$2.67 - $4.97 $262,111 - $487,899	98,169 Added 20.66%	573,398 $1.81 Million
Q4 2019 Feb 13, 2020	BUY	$2.93 - $4.5 $201,337 - $309,222	68,716 Added 16.9%	475,229 $1.91 Million
Q3 2019 Nov 12, 2019	BUY	$3.08 - $5.76 $41,552 - $77,708	13,491 Added 3.43%	406,513 $1.76 Million
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.32 $185,749 - $338,309	53,530 Added 15.77%	393,022 $1.57 Million
Q1 2019 May 14, 2019	BUY	$5.36 - $7.24 $164,653 - $222,405	30,719 Added 9.95%	339,492 $1.82 Million
Q4 2018 Feb 13, 2019	BUY	$4.8 - $11.6 $32,692 - $79,007	6,811 Added 2.26%	308,773 $1.58 Million
Q3 2018 Nov 13, 2018	BUY	$9.05 - $10.95 $143,913 - $174,126	15,902 Added 5.56%	301,962 $2.93 Million
Q2 2018 Aug 14, 2018	BUY	$10.2 - $13.9 $276,369 - $376,620	27,095 Added 10.46%	286,060 $2.92 Million
Q1 2018 May 15, 2018	BUY	$12.65 - $18.85 $736,014 - $1.1 Million	58,183 Added 28.98%	258,965 $3.37 Million
Q4 2017 Feb 13, 2018	BUY	$17.45 - $25.6 $89,884 - $131,865	5,151 Added 2.63%	200,782 $3.59 Million
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $116,877 - $174,388	6,184 Added 3.26%	195,631 $4.91 Million
Q2 2017 Aug 14, 2017	BUY	N/A	189,447	189,447 $4.57 Million

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account